Arena Surges on FDA Approval

[cnbc 3000099250]

Shares of Arena Pharmaceuticals spiked on news the FDA approved its anti-obesity drug, with the Fast Money traders; and discussing how tomorrow’s ruling on the health care reform could impact the biotech sector, with Mark Schoenebaum, ISI.

Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell Fast Money hosts one of the best trading discussions of the day.

Video © and provided by CNBC.